2019 American Transplant Congress » Poster Session C: Lung: All Topics

6:00pm-7:00pm

Effect of Donor-Recipient Serologic CMV Matching on 1-Year Post-Lung Transplant Outcomes

H. Ehrenfeld, M. Manson, R. Yau

6:00pm-7:00pm

Anti-Fungal Prophylaxis in Lung Transplant: A Systematic Review/Meta-Analysis

K. Pennington, M. Baqir, P. Erwin, H. Murad, R. Razonable, C. C. Kennedy

6:00pm-7:00pm

Assessment Of Glomerular Filtration Rate Among Lung Transplant Candidates

S. Akkina¹, S. Hou², D. Jain Arwindekar², A. Desai²

6:00pm-7:00pm

Azole Use and Fungal Pathogens in Cystic Fibrosis versus Non-Cystic Fibrosis Lung Transplant Recipients

F. J. Marco Canosa¹, K. Brizendine², H. Hassouna³

6:00pm-7:00pm

Caregiving before Thoracic Transplantation–A Qualitative Inquiry

C. C. Kennedy¹, J. Ridgeway¹, E. Stevens¹, J. Kirsch², K. Carroll¹, J. Griffin¹, R. Benzo¹

6:00pm-7:00pm

Cellular And Molecular Characteristics Of Intra-graft Lymphoid Aggregates In Chronic Lung Allograft Dysfunction

E. Miyamoto¹, S. Juvet¹, D. Hwang², S. Keshavjee¹, T. Martinu¹

6:00pm-7:00pm

Clinical Outcomes of Using mTOR Inhibitors with Reduced Dose of Calcineurin Inhibitors in Lung Transplant Recipients: A Single Center Experience

M. Frawley¹, J. Leedy¹, A. James¹, A. Salter¹, V. Rusanov²

6:00pm-7:00pm

Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction

S. Mietz¹, D. Roe², E. Lushin¹, E. Anderson¹, C. Hage²

6:00pm-7:00pm

Correlation between Gene Expression and Histology in Transbronchial Lung Transplant Biopsies

B. Adam, K. Du, S. Rotich, M. Mengel

6:00pm-7:00pm

Effect of Enoxaparin Prophylaxis on Early VTE Post Lung Transplant

S. Marshall¹, K. Tsveybel¹, S. Boukedes¹, P. Burkett², R. Chepuri², A. Coppolino³, M. Divo², S. El-Chemaly², S. Keller², J. Kennedy², H. Mallidi³, G. Mody³, T. Thaniyavarn², A. Trindade², K. Townsend¹, H. Goldberg²

6:00pm-7:00pm

Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation

J. Choe, J. Au, A. Diamond, C. Ruggia-Check, S. Sehgal, F. Cordova, N. Shigemura, S. Keshavamurthy, Y. Toyoda

6:00pm-7:00pm

Frailty is Highly Prevalent in Lung Transplant Candidates and Varies by Frailty Tool

A. O'Boye, K. Leitner, M. Kelly, J. Wright, J. Lee, M. Sala, R. Tomic, S. Bhorade

6:00pm-7:00pm

Impact Of Inhaled Vasodilator Therapy On Early Morbidity And Mortality After Lung Transplant

M. Tomeczkowicz¹, A. Wexler¹, M. Patel², J. Fernandez-Castillo², J. Rusniak¹, E. Mancl³, S. Quddus²

6:00pm-7:00pm

Impact of Size Mismatch on Long-Term Graft Survival after Orthotopic Liver Transplantation

K. Kamrani¹, A. Okoh², A. Mathur³, L. Brown⁴

6:00pm-7:00pm

Impact of the 2013 Change in Definition of Increased Risk Donors on Lung Transplant Outcomes

C. J. Lehr¹, R. Lopez², S. Arrigain², J. D. Schold², M. Valapour¹

6:00pm-7:00pm

Inadequate (ax) Transbronchial Biopsies Are Not Associated With Clad Or Death After Lung Transplantation

L. Levy¹, E. Huszti², J. Tikkanen³, R. Ghany³, S. Keshavjee³, T. Martinu³

6:00pm-7:00pm

Lung Allocation Score Should Be Implemented in China

C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He

6:00pm-7:00pm

Lung Transplantation in the Elderly Patients with Multi-Comorbidities

N. Shigemura, Y. Toyoda

6:00pm-7:00pm

Molecular Features of Rejection in Endobronchial Mucosa Biopsies

M. D. Parkes, K. M. Halloran, J. Chang, P. F. Halloran and The INTERLUNG Study Group

6:00pm-7:00pm

Obesity Induced IL-18 Production Impairs FOXP3+ Treg Function and Increases Risk of Primary Graft Dysfunction in Lung Transplant Recipients

W. W. Hancock¹, T. Zhang¹, U. H. Beier¹, A. Samanta¹, R. Han¹, L. Wang¹, J. Jiao¹, J. M. Diamond², D. S. Wilkes³, D. J. Lederer⁴, R. A. Simmons², J. D. Christie², T. Akimova²

6:00pm-7:00pm

Oral Ribavirin Therapy for Respiratory Syncytial Virus (RSV) in Lung Transplant Recipients: The Impact of Policy Implementation on Cost and Appropriate Use

B. Berak, N. Sulejmani, A. Jantz, T. Larson, S. Davis, B. Summers

6:00pm-7:00pm

Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease

A. J. Trindade¹, P. Burkett¹, S. El-Chemaly¹, N. Hashemi², T. Thaniyavarn¹, H. R. Mallidi³, H. J. Goldberg¹

6:00pm-7:00pm

Patient-Reported Self-Management in Lung Transplant Candidates

C. C. Kennedy¹, M. Budev², S. Chandrashekaran³, D. Erasmus⁴, E. D. Lease⁵, D. Levine⁶, K. Thompson¹, E. Stevens¹, R. Benzo¹

6:00pm-7:00pm

Pre-Transplant Patient and Caregiver Assessments: A Systematic Review and Meta-Analysis

J. Lau, A. A. Rmilah, R. Mendpara, P. J. Erwin, C. C. Kennedy

6:00pm-7:00pm

Simulation of DSA-Free Lung Allocation

M. Skeans¹, J. Pyke¹, K. Audette¹, R. Lehman², K. Uccellini², K. M. Chan³, E. D. Lease⁴, R. Daly⁵, M. Valapour⁶

6:00pm-7:00pm

Simulation vs. Reality: 250NM as First Unit of Lung Allocation

M. Skeans¹, J. Pyke¹, C. Lehr², R. Lehman³, K. Uccellini³, K. M. Chan⁴, E. D. Lease⁵, R. Daly⁶, M. Valapour²

6:00pm-7:00pm

Synergistic Effect of HLA Eplet Mismatch Load and CMV Viremia on Clinical Antibody-Mediated Rejection in Lung Transplantation

Y. Im¹, S. Yeramaneni², Y. Yim³, J. Dodderer⁴, M. Askar¹, H. J. Huang⁵

6:00pm-7:00pm

The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome

B. Lindner¹, S. Strout¹, P. Shah²

6:00pm-7:00pm

The Molecular Features of Chronic Lung Allograft Dysfunction (CLAD) in Transbronchial and Endobronchial Mucosa Biopsies

M. D. Parkes¹, K. M. Halloran¹, J. Chang², P. F. Halloran and the INTERLUNG study group¹

6:00pm-7:00pm

Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension

C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen

6:00pm-7:00pm

­Pediatric Heart and Lung Graft Loss during the “High-Risk Age Window”

J. Long¹, J. Motter¹, K. R. Jackson¹, M. Kosztowski¹, B. Orandi², X. Luo¹, K. Van Arendonk³, A. Massie¹, E. Bush¹, R. S. Higgins¹, D. L. Segev¹, J. M. Garonzik-Wang¹